Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-05-16

Clinical Trial Update: Laryngeal Vibro-tactile Stimulation as a Non-invasive Symptomatic Treatment for Spasmodic Dysphonia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating laryngeal vibro-tactile stimulation for spasmodic dysphonia has been withdrawn. The sponsor is University of Minnesota and the conditio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Minnesota | Conditions: Adductor Spasmodic Dysphonia, Abductor Spastic Dysphonia | Phase 2 | Status: WITHDRAWN